Johnson & Johnson Lung Cancer Initiative
See all stories about the Johnson & Johnson Lung Cancer Initiative, and learn how J&J is working toward a world where fewer people die from lung cancer.
Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.
“My 2021 healthcare resolution": 7 Johnson & Johnson leaders share their goals for advancing healthcare and health equity
A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they’re already hard at work on them.
She oversees one of the world’s largest healthcare businesses: 7 questions for Ashley McEvoy in the time of COVID-19
Johnson & Johnson develops consumer products, medical devices and pharmaceuticals—and McEvoy is at the helm of its global Medical Devices Companies. She shares how she has navigated the pandemic, grown professionally and personally as a result, and helped impact the lives of millions during this unique moment in history.
Health & wellness
Health & wellness
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what’s to come in better detecting and preventing it.
Some 20% of people diagnosed with the disease haven’t touched a cigarette. For Healthy Lung Month, scientists who’ve dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
The doctor overseeing the company’s new Lung Cancer Initiative reveals why it’s uniquely qualified to work on thwarting the disease—and why he’s uniquely qualified to oversee its efforts.
University and company researchers will work closely over the next five years to identify ways to better detect and treat the deadliest cancer in the world.